CD24 regulates liver immune response and ameliorates acute hepatic injury through controlling hepatic macrophages.

IF 4.5 3区 医学 Q2 IMMUNOLOGY
Jian Zheng, Jun Xiao, Yatong Fan, Honggang Zheng, Hongyu Liu, Jie Xiang, Lei Hai, Yan Wang, Xuejun Zhang
{"title":"CD24 regulates liver immune response and ameliorates acute hepatic injury through controlling hepatic macrophages.","authors":"Jian Zheng, Jun Xiao, Yatong Fan, Honggang Zheng, Hongyu Liu, Jie Xiang, Lei Hai, Yan Wang, Xuejun Zhang","doi":"10.1002/eji.202451178","DOIUrl":null,"url":null,"abstract":"<p><p>Liver injury releases danger-associated molecular patterns, which trigger the immune response. CD24 negatively regulates the immune response by binding with danger-associated molecular patterns, but the specific role of CD24 in modulating macrophage-related inflammation during liver injury remains largely unexplored. Here, we aimed to investigate the mechanisms of macrophage CD24 in the development of liver injury. Our results show that CD24 expression is upregulated primarily in hepatic macrophages (HMs) during acute liver injury. CD24-deficient mice exhibited more severe liver injury and showed a significantly higher frequency and number of HMs, particularly Ly6C<sup>hi</sup> monocyte-derived macrophages. Mechanistically, the CD24-Siglec-G interaction plays a vital role in mitigating acute liver injury. CD24-mediated inhibitory signaling in HMs primarily limits downstream NF-κB and p38 MAPK activation through the recruitment of SHP1. Our work unveils the critical role of macrophage CD24 in negatively regulating innate immune responses and protecting against acute liver injury, thus providing potential therapeutic targets for liver-associated diseases.</p>","PeriodicalId":165,"journal":{"name":"European Journal of Immunology","volume":" ","pages":"e2451178"},"PeriodicalIF":4.5000,"publicationDate":"2024-10-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Immunology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1002/eji.202451178","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Liver injury releases danger-associated molecular patterns, which trigger the immune response. CD24 negatively regulates the immune response by binding with danger-associated molecular patterns, but the specific role of CD24 in modulating macrophage-related inflammation during liver injury remains largely unexplored. Here, we aimed to investigate the mechanisms of macrophage CD24 in the development of liver injury. Our results show that CD24 expression is upregulated primarily in hepatic macrophages (HMs) during acute liver injury. CD24-deficient mice exhibited more severe liver injury and showed a significantly higher frequency and number of HMs, particularly Ly6Chi monocyte-derived macrophages. Mechanistically, the CD24-Siglec-G interaction plays a vital role in mitigating acute liver injury. CD24-mediated inhibitory signaling in HMs primarily limits downstream NF-κB and p38 MAPK activation through the recruitment of SHP1. Our work unveils the critical role of macrophage CD24 in negatively regulating innate immune responses and protecting against acute liver injury, thus providing potential therapeutic targets for liver-associated diseases.

CD24 通过控制肝巨噬细胞调节肝脏免疫反应并改善急性肝损伤。
肝损伤会释放危险相关分子模式,从而引发免疫反应。CD24通过与危险相关分子模式结合来负向调节免疫反应,但CD24在肝损伤过程中调节巨噬细胞相关炎症的具体作用在很大程度上仍未被探索。在此,我们旨在研究巨噬细胞 CD24 在肝损伤发生过程中的作用机制。我们的研究结果表明,在急性肝损伤过程中,CD24主要在肝巨噬细胞(HMs)中表达上调。CD24 缺陷小鼠表现出更严重的肝损伤,并显示出明显更高的 HMs 频率和数量,尤其是 Ly6Chi 单核细胞衍生巨噬细胞。从机理上讲,CD24-Siglec-G 的相互作用在减轻急性肝损伤中起着至关重要的作用。CD24 介导的 HMs 抑制信号主要通过招募 SHP1 来限制下游 NF-κB 和 p38 MAPK 的激活。我们的研究揭示了巨噬细胞 CD24 在负向调节先天性免疫反应和保护肝脏免受急性损伤中的关键作用,从而为肝脏相关疾病提供了潜在的治疗靶点。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
8.30
自引率
3.70%
发文量
224
审稿时长
2 months
期刊介绍: The European Journal of Immunology (EJI) is an official journal of EFIS. Established in 1971, EJI continues to serve the needs of the global immunology community covering basic, translational and clinical research, ranging from adaptive and innate immunity through to vaccines and immunotherapy, cancer, autoimmunity, allergy and more. Mechanistic insights and thought-provoking immunological findings are of interest, as are studies using the latest omics technologies. We offer fast track review for competitive situations, including recently scooped papers, format free submission, transparent and fair peer review and more as detailed in our policies.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信